Aptevo Therapeutics Inc. (APVO) financial statements (2022 and earlier)

Company profile

Business Address 2401 4TH AVE.
SEATTLE, WA 98121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,044 12,44830,63580,78354,525
Cash and cash equivalents45,044 12,44830,6357,0959,676
Short-term investments    73,68844,849
Restricted cash and investments1,259   400 
Receivables3,664 7,0225,2202,1414,284
Inventory, net of allowances, customer advances and progress billings  6,1391,7851,0286,639
Inventory  6,1391,7851,0286,639
Prepaid expense1,823 4,2266,907  
Other current assets780 1604,1426,710 
Other undisclosed current assets    4,0225,966
Total current assets:52,570 29,99548,68995,08471,414
Noncurrent Assets
Operating lease, right-of-use asset1,584 3,747
Property, plant and equipment2,379 3,9465,2025,8435,910
Long-term investments and receivables     (3,300)
Accounts and financing receivable, after allowance for credit loss     (3,300)
Intangible assets, net (including goodwill)  4,4205,2506,08014,534
Intangible assets, net (excluding goodwill)  4,4205,2506,08014,534
Restricted cash and investments  7,4987,44810,000 
Other noncurrent assets68 3,802905  
Other undisclosed noncurrent assets     3,300
Total noncurrent assets:4,031 23,41318,80521,92320,444
TOTAL ASSETS:56,601 53,40867,494117,00791,858
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,077 3,5243,8984,6264,009
Employee-related liabilities2,077 3,5243,8984,6264,009
Debt11,667 19,863 3,333 
Deferred revenue and credits 811
Other liabilities2,086 1,0837963,201 
Other undisclosed current liabilities18,927 13,76912,9167,35014,724
Total current liabilities:34,757 38,23917,61018,51019,544
Noncurrent Liabilities
Long-term debt and lease obligation5,048 3,32719,27815,72818,383
Long-term debt, excluding current maturities3,707  19,27815,72818,383
Operating lease, liability1,341 3,327
Liabilities, other than long-term debt   2007343,365
Deferred revenue and credits 2,896
Other liabilities   200734469
Other undisclosed noncurrent liabilities14,239     
Total noncurrent liabilities:20,628 3,32719,47816,46221,748
Total liabilities:55,385 41,56637,08834,97241,292
Stockholders' equity
Stockholders' equity attributable to parent, including:1,216 11,84230,40682,03550,566
Common stock47 45232220
Additional paid in capital215,232 179,653157,791155,837151,271
Accumulated other comprehensive loss    (105)(33)
Accumulated deficit(214,063) (167,856)(127,408)(73,719)(80,692)
Other undisclosed stockholders' equity attributable to parent     (20,000)
Total stockholders' equity:1,216 11,84230,40682,03550,566
TOTAL LIABILITIES AND EQUITY:56,601 53,40867,494117,00791,858

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues12,292 32,42423,06714,65836,434
Revenue, net14,65836,434
Cost of revenue
(Cost of Goods and Services Sold)
  (19,927) (5,010)(24,182)
Gross profit:12,292 12,49723,0679,64812,252
Operating expenses(33,692) (55,093)(63,518)(63,597)(139,197)
Other undisclosed operating loss   (11,214)  
Operating loss:(21,400) (42,596)(51,665)(53,949)(126,945)
Nonoperating income (expense)(8,008) 2,148(2,024)(1,944)(810)
Investment income, nonoperating  4,250   
Other nonoperating expense(8,008) (2,102)(2,024)(1,944)(810)
Interest and debt expense  (2)   
Loss from continuing operations before equity method investments, income taxes:(29,408) (40,450)(53,689)(55,893)(127,755)
Other undisclosed loss from continuing operations before income taxes  (4,248)   
Loss from continuing operations before income taxes:(29,408) (44,698)(53,689)(55,893)(127,755)
Income tax benefit    23,30115,340
Loss from continuing operations:(29,408) (44,698)(53,689)(32,592)(112,415)
Income from discontinued operations951 4,250 39,565 
Net income (loss) available to common stockholders, diluted:(28,457) (40,448)(53,689)6,973(112,415)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):(28,457) (40,448)(53,689)6,973(112,415)
Comprehensive income (loss):(28,457) (40,448)(53,689)6,973(112,415)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   105(72)(33)
Comprehensive income (loss), net of tax, attributable to parent:(28,457) (40,448)(53,584)6,901(112,448)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: